President and CEO of Neoleukin Therapeutics, Inc. (NASDAQ:NLTX), Walkey Carl, sells 3,000 shares worth $42,600
According to Neoleukin Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Feb 12 04:23 PM, company President and CEO, Walkey Carl disclosed selling 3,000 shares at a cost of $14.20. At the time of this transaction (Feb 10), this trade was worth $42,600 in total. As of Feb 10, Walkey Carl now owns 1,379,962 shares in total worth about $17,221,925.76.
For the last few recent trades made by Neoleukin Therapeutics, Inc. (NASDAQ:NLTX) President and CEO, Walkey Carl, we have the following information:
- SEC Form 4 filing: Feb 05: Sold 600 shares at the rate of $14.00 per share. Total worth of this trade was $8,400. Total number of shares owned as of Feb 05 were 1,382,962
- SEC Form 4 filing: Feb 03: Sold 2,400 shares at the rate of $13.23 per share. Total worth of this trade was $31,752. Total number of shares owned as of Feb 03 were 1,383,562
Posted by
George Daniels
on Friday February 12 2021, 6:23 PM EST.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
